Series C - Vividion Therapeutics
Investment Firm
Overview
Vividion is a developer of a novel drug discovery platform designed to offer transformative treatments to patients with serious illnesses.
Announced Date
Feb 24, 2021
Funding Type
Series C
Highlights
Location
United States, North America
Social
Participant Investors
13
Round Details and Background
Vividion Therapeutics raised $135000000 on 2021-02-24 in Series C
Vividion is a developer of a novel drug discovery platform designed to offer transformative treatments to patients with serious illnesses.
Company Funding History
5
| Announcment Date | Transaction Name | Number Of Investors | Lead Investor | Money Raised |
|---|---|---|---|---|
| Apr 30, 2019 |  Series B - Vividion Therapeutics | 12 | - | 82.0M |
| Feb 24, 2021 | Series C - Vividion Therapeutics | 16 | - | 135.0M |
| Feb 02, 2017 | Series A - Vividion Therapeutics | 3 | - | 50.0M |
| Apr 11, 2016 | Series A - Vividion Therapeutics | 1 | - | 3.5M |
Recent Activity
There is no recent news or activity for this profile.